BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2005
View Archived Issues
UCB profiles recent pipeline developments
Read More
NG2-73 enters phase II for insomnia
Read More
Roche and Maxygen to codevelop recombinant factor VIIa products
Read More
Zadaxin and pegylated interferon alpha fail to demonstrate statistically significant benefit in HCV
Read More
ActivBiotics and Metaphore sign merger agreement
Read More
Amgen to acquire Abgenix
Read More
Anadys selects ANA-773 as drug development candidate for cancer
Read More
Plavix recommended for use in new PAD guidelines
Read More
FDA Advisory Committee vote positively on Rotateq
Read More
Phase I/II study investigates CB-7630 for advanced prostate cancer
Read More
European CHMP to issue updated positive opinion for Macugen
Read More
Alnylam and sanofi pasteur update status of avian flu projects
Read More
Protox submits IND for phase I trials of PRX-302
Read More
Maximum tolerated dose determined for Anyara
Read More
MN-001 significantly improves measures of respiratory function in asthma patients
Read More
Preclinical and clinical antitumor activity of atiprimod reported
Read More
Bendamustine effective against refractory or relapsed non-Hodgkin's lymphoma and multiple myeloma
Read More
Clinical efficacy of forodesine for refractory/relapsed cutaneous T-cell lymphoma and leukemia
Read More
Motexafin gadolinium improves survival of mice with ALS
Read More
Preclinical profile of SCA-136 disclosed by Wyeth
Read More
Antalarmin lacks efficacy in primate models of cocaine self-administration and discrimination
Read More
CB2 receptor agonist slows ALS progression in mice
Read More
Spotlight on rufinamide from American epilepsy meeting
Read More
Tamiflu gains positive European and Swiss opinions for child flu prevention
Read More
Depakote ER receives new approval in bipolar disorder
Read More
Initiation of rolling NDA for satraplatin in hormone-refractory prostate cancer
Read More
Pharmasset present data on their new anti-HCV agent
Read More
Recent patents report new therapeutic agents for metabolic disorders
Read More
Novel agents with potential for treatment of pain described
Read More